ARENSIA Exploratory Medicine is a privately owned company specialized in the performance of early clinical trials in patients: Phase I/Ib/IIa and PROOF OF CONCEPT, conducted in hospital based clinical pharmacology units in Eastern Europe.
ARENSIA brings together large patient populations, incl. treatment naïve, with year long know-how in exploratory clinical trials. The combination of resources and skills is highly potent: we are able to conduct the most complex studies, in patients, in a Phase I set-up.
The company has strategic, exclusive partnerships with reputable university and clinical hospitals in Romania, Republic of Moldova and Lithuania for exploratory development projects.
Our units serve following therpeutic areas:
immuno-inflammatory, cardiovascular, diabetes/metabolic, respiratory, hepatology, nephrology, gastroenterology, infectious diseases HCV/HIV, urology, oncology, dermatology, neurology, psychiatry
ARENSIA has expertise to perform sophisticated designs and clinical investigations within a scientific environment: intensive PK and PD schedules, long hospitalization, invasive and non-invasive techniques.
Latest imaging technology is available e.g. MRI, CT, PET, etc.
The timelines for regulatory approval are reliable and competitive:
4 weeks for Moldova and 8 weeks for Romania and Lithuania.
ARENSIA has repeat business with the major international Sponsors.